PHARMAQ's manufacturing facility

All PHARMAQ's vaccines are manufactured at our well recognized facility at Overhalla in Norway. We are proud to meet the stringent requirements from various authorities for pharmaceutical industry quality systems. The manufacturing capacity is adapted to the growing demand for a variety of vaccines.

As a pharmaceutical company, PHARMAQ is subject to very stringent demands, regulated in the principles and guidance of Good Manufacturing Practice (GMP). PHARMAQ's manufacturing facility is, on a regular basis, -approved according to GMP by the Norwegian Medicines Agency (NoMA).

Our focus on quality is absolute in all steps of production, from raw materials to finished products.

Quality is built in every operation, from development to the final product is approved by the authorities and released for sale by a QP (Qualified Person - approved by the authorities).

Manufacturing vaccines requires highly qualified personnel with special knowledge of aseptic production in a technical environment. Comprehensive training programs and validations are important activities to secure the run and maintenance of production equipments in the different process lines.